H-吴越投资2020-03-04 21:57
春节期间对血液灌流治疗进行初步研究,对采用全血灌流和血浆灌流的产品做了一些疏理,附以我个人的一些理解。相关公司列表如下:
表一、血浆吸附:
注:
(1)血浆吸附模式提前将血液中的血细胞分离出来,吸附效率更佳,还可以避免或减少血液相容性问题。血液相容性可能是因为离子树脂...查看全文
$Cytosorbents Corporation(CTSO)$ S-8 - Securities to be offered to employees in employee benefit plans Filed: 2017-09-26 AccNo: 0001144204-17-049552 Size: 259 KB 网页链接
$Cytosorbents Corporation(CTSO)$ 8-K - Current report Filed: 2017-08-09 AccNo: 0001144204-17-041302 Size: 147 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$Cytosorbents Corporation(CTSO)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2017-08-07 AccNo: 0001144204-17-040844 Size: 3 MB 网页链接
$Cytosorbents Corporation(CTSO)$ 美东时间 2017-08-07 盘后 披露财报,预期EPS -0.06 网页链接
$Cytosorbents Corporation(CTSO)$ 8-K - Current report Filed: 2017-07-06 AccNo: 0001144204-17-035945 Size: 120 KBItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$CYTOSORBENTS CORP(CTSO)$ 内部交易: 2017-06-09,Chief Medical Officer,Mortensen Eric R. ,买入,2500普通股, $4.04
$CYTOSORBENTS CORP(CTSO)$ 内部交易: 2017-06-09,Director,BATOR MICHAEL G. ,买入,1500普通股, $4.12
$CYTOSORBENTS CORP(CTSO)$ 内部交易: 2017-06-08,Director,Jones Edward Raymond ,买入,2500普通股, $3.99
$CYTOSORBENTS CORP(CTSO)$ 内部交易: 2017-06-08,总裁 and CEO,Chan Phillip P. ,买入,3700普通股, $4.00
$CYTOSORBENTS CORP(CTSO)$ 内部交易: 2017-06-08,COO,Capponi Vincent ,买入,2500普通股, $4.00